50 years after #IL-2, #GVN’s Dr. Robert C. Gallo (USF Health; TGH) reflects in STAT on its unexpected impact on human #retrovirology, #HIV and cancer immunotherapy, and why we can’t “just fund the obvious.”

Read: https://ow.ly/8vST50ZWmkq